Complex Chemistry / Drug Substance / API & HPAPI Development and Manufacturing — CDMO
Wilmington PharmaTech is a US-based CDMO specializing in complex small-molecule API development and cGMP manufacturing, supporting pharma and biotech companies from early discovery through commercial supply. Despite a strong scientific track record, including work supporting hundreds of drug substance programs over 200 IND submissions, the company had very limited visibility due to an outdated brand and minimal marketing investment.
Developed a new brand for Wilmington PharmaTech capable of translating its deep scientific expertise and complex chemistry capabilities into a clear, compelling market narrative.
Repositioned Wilmington PharmaTech, providing the brand infrastructure needed to support its next phase of growth.
